FDA approves Rexulti for dementia patients dealing with agitation

The Food and Drug Administration on Thursday announced the supplemental approval Alzheimer ' s disease drug Rexulti which deals with agitation.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news